Chia Tai Enterprises International Limited
HKSE: 3839.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Chawalit Na Muangtoun
- Employees
- 900
- Headquarters
- Central, Hong Kong SAR China
- IPO year
- 2015
- Market cap
- HK$2.2B
- Website
- https://www.ctei.com.hk
Loading 3839…
Loading profile data…Frequently asked questions about 3839
What does Chia Tai Enterprises International Limited (3839.HK) do?
Chia Tai Enterprises International Limited engages in the manufacture and sale of chlortetracycline (CTC) and other related products in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments, Biochemical and Industrial. The Biochemical segment manufactures and sells CTC premix and CTC hydroc...
Where does 3839.HK trade?
Chia Tai Enterprises International Limited (3839.HK) trades on the Hong Kong Stock Exchange.
What sector is 3839.HK in?
Chia Tai Enterprises International Limited (3839.HK) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Chia Tai Enterprises International Limited?
Chawalit Na Muangtoun is the chief executive officer of Chia Tai Enterprises International Limited (3839.HK).
Where is Chia Tai Enterprises International Limited headquartered?
Chia Tai Enterprises International Limited is headquartered in Hong Kong SAR China.
Does 3839.HK pay a dividend?
Chia Tai Enterprises International Limited (3839.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 3839.HK go public?
Chia Tai Enterprises International Limited (3839.HK) completed its initial public offering in 2015.